Sarepta Therapeutics
SRPT
#2387
Rank
ยฃ4.46 B
Marketcap
ยฃ46.05
Share price
-0.74%
Change (1 day)
-53.83%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) Fails to deliver data

Key failure to deliver metrics for Sarepta Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Sarepta Therapeutics (SRPT) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Sarepta Therapeutics (SRPT) - since 2013

Volume in USD (price x number of shares), data since 2013

Sarepta Therapeutics (SRPT) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ0.8 M-98.07%
2024ยฃ41.97 M24.73%
2023ยฃ33.65 M66.59%
2022ยฃ20.2 M-64.04%
2021ยฃ56.17 M-40.62%
2020ยฃ94.6 M-66.33%
2019ยฃ0.28 B16.72%
2018ยฃ0.24 B253.79%
2017ยฃ68.05 M-40.35%
2016ยฃ0.11 B190.97%
2015ยฃ39.21 M-69.48%
2014ยฃ0.12 B79.12%
2013ยฃ71.71 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
ยฃ0.15 Bยฃ0.24 B๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.51 Mยฃ0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ4.02 Mยฃ15.59 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.37 Mยฃ2.9 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ9.85 Mยฃ37.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ27.72 Mยฃ30.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ17.72 Mยฃ55.62 M๐Ÿ‡บ๐Ÿ‡ธ USA